This statistic shows the ranking of the global top 10 biotech and pharmaceutical companies worldwide, based on revenue.
GlaxoSmithKline was the global leader based on revenues generated through vaccine products in 2017 and is forecasted to maintain this position up to 2024. The London-based pharmaceutical manufacturer generates around one fifth of its total revenue through the vaccines segment. GlaxoSmithKline’s vaccines...
Novartis has about 100,000 employees and has a product-reach in over 180 countries. Novartis occupies ranks among the top pharma companies in the Fortune Global 500 Companies list. An annual revenue of more than $50 billion and R & D expenditure of $8 billion make it a strong company. Th...
2022 revenue: $66.26 billion From their conception 125 years ago, Roche has become one of the largest pharmaceutical companies in the world. Having evolved into a global leader in the industry, they specialise in diagnostics and pharmaceuticals, with dominance in cancer treatments due to their popu...
The pharmaceutical industry continues to generate stellar growth and was estimated to be worth an impressive US$1.6 trillion in 2023 with top 10 pharma companies contributing US$491.84 billion, nearly a third of all revenues. In this blog, we reveal the
New analysis from GlobalData has revealed the top 20 pharma companies by revenue for 2018, with Johnson & Johnson, Roche and Pfizer leading the pack, but Takeda, Celgene and AbbVie seeing strong growth
RELATED:The top 20 pharma companies by 2020 revenue Xtandi has also had to contend with Bayer rival Nubeqa, whichpicked upan edge last January on data showing it could prolong nmCRPC patients’ lives when used on top of androgen deprivation therapy (ADT). ...
Right. I'm starting to see why you joined GoodRx, by the way, it's starting to become clear. So the relationship among patients, the doctors, the pharma companies, sounds like it's shifting, continues to shift and has done over recent years. And how is that going to evolve, continue...
Danugliplon was anticipated to rival Novo Nordisk’s Wegovy and Lilly’s Mounjaro in the weight loss drug market, amid efforts to mitigate post-COVID declines in revenue. Bristol-Myers Squibb reported a market capitalization decline of 3...
Source: GlobalData Pharma Intelligence Center and Annual Reports. ©GlobalData. The biopharmaceutical industry experienced varied revenue shifts in 2023, with significant success for companies with obesity drugs. Over half (13) of the top 20 publicly traded global innovative biopharmaceutical ...